Creating special gels to help heal diabetic wounds faster
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
This study is testing a new gel designed to help heal diabetic wounds better by creating a supportive structure that reduces inflammation and helps new tissue grow, making it easier for patients to recover.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10875610 on NIH RePORTER |
What this research studies
This research focuses on developing a new type of hydrogel called Microporous Annealed Particle gel (MAP gel) to enhance the healing process of diabetic wounds. The MAP gels are engineered using microscopic spherical particles that form a scaffold to support tissue repair. The study aims to optimize the properties of these gels, such as pore geometry and degradability, to reduce inflammation and promote better integration of new tissue. By addressing common challenges in diabetic wound healing, this research seeks to improve patient outcomes significantly.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetic foot ulcers or other diabetic wounds that are slow to heal.
Not a fit: Patients with non-diabetic wounds or those who do not have diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective healing of diabetic wounds, reducing complications and improving quality of life for patients.
How similar studies have performed: Previous research has shown promise in using biomaterials for wound healing, suggesting that this approach could be effective.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Griffin, Donald Richieri — University of Virginia
- Study coordinator: Griffin, Donald Richieri
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.